Codexis (CDXS) Cash from Operations (2010 - 2026)
Codexis (CDXS) recorded quarterly Cash from Operations of 13150000.0 in Q1 2026, down 165.45% quarter-over-quarter from 20092000.0 in Q4 2025, and up 4.7% on a YoY basis from 12560134.29 in Q1 2025.
Codexis (CDXS) Cash from Operations (2010 - 2026) Analysis & Trends
Codexis' Cash from Operations history runs 17 years deep, the most recent figure standing at 13150000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 4.7% year-over-year to 13150000.0; the TTM figure through Mar 2026 stood at 18728000.0 (up 66.21% YoY), while the FY2025 annual figure was 19376000.0, up 60.79% from the prior year.
- Cash from Operations was 13150000.0 for Q1 2026 at Codexis, down from 20092000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 20092000.0 in Q4 2025 to a low of 17967000.0 in Q2 2025.
- Historically, Cash from Operations has averaged 7252352.94 across 5 years, with a median of 11186000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations soared 10378.12% in 2022, then plunged 637.6% in 2023.
- A 5-year view of Cash from Operations shows it stood at 4917000.0 in 2022, then slumped by 324.47% to 11037000.0 in 2023, then slumped by 49.21% to 16468000.0 in 2024, then surged by 222.01% to 20092000.0 in 2025, then sank by 165.45% to 13150000.0 in 2026.
- The last three Cash from Operations figures came in at 13150000.0 (Q1 2026), 20092000.0 (Q4 2025), and 7703000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | -13.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.15 Mn |
| Mar 31, 2026 | -13.15 Mn |
| Dec 31, 2025 | 20.09 Mn |
| Dec 31, 2025 | 20.09 Mn |
| Sep 30, 2025 | -7.70 Mn |
| Sep 30, 2025 | -7.70 Mn |
| Jun 30, 2025 | -17.97 Mn |
| Jun 30, 2025 | -17.97 Mn |
| Mar 31, 2025 | -13.80 Mn |
| Mar 31, 2025 | -13.80 Mn |
| Dec 31, 2024 | -16.47 Mn |
| Dec 31, 2024 | -16.47 Mn |
| Sep 30, 2024 | -12.99 Mn |
| Sep 30, 2024 | -12.99 Mn |
| Jun 30, 2024 | -12.17 Mn |
| Jun 30, 2024 | -12.17 Mn |
| Mar 31, 2024 | -7.79 Mn |
| Mar 31, 2024 | -7.79 Mn |
| Dec 31, 2023 | -11.04 Mn |
| Dec 31, 2023 | -11.04 Mn |